{"id":"W4409595460","doi":"10.1016/j.lungcan.2025.108551","title":"Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Takeda Pharmaceutical Company; Takeda Pharmaceuticals U.S.A.; AstraZeneca; LUNGevity Foundation","keywords":"Medicine; Afatinib; Osimertinib; Oncology; Lung cancer; Internal medicine; Cancer; Erlotinib; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003731868,0.0004895507,0.0009755354,0.001013899,0.0003038389,0.001142564,0.0006458619,0.0006024434,0.001379383],"category_scores_gemma":[0.003782474,0.0002304144,0.002659895,0.001079505,0.0004242118,0.0008003447,0.0008156453,0.0008063948,0.0001827497],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001580855,"about_ca_system_score_gemma":0.0006367951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002040746,"about_ca_topic_score_gemma":0.003623341,"domain_scores_codex":[0.9980324,0.0008316233,0.0002368971,0.0004130827,0.0002335222,0.0002524348],"domain_scores_gemma":[0.9951309,0.001311103,0.002569633,0.0002581296,0.0001972053,0.0005331348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06569479,0.0009905921,0.8901057,0.0003573869,0.006672682,0.0002688894,0.0002348323,0.004645356,0.002231046,0.0001135981,0.000860244,0.02782487],"study_design_scores_gemma":[0.002348232,0.02161274,0.9575483,0.00007840894,0.005104274,0.001121338,0.000335288,0.009017364,0.001440055,0.0001570562,0.001168013,0.00006897894],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986383,0.0005629595,0.0001014937,0.00003919946,0.000004911416,0.00001889734,0.000471444,0.000005247115,0.000157524],"genre_scores_gemma":[0.999088,0.0001396513,0.0001029232,0.00003317447,0.00001288182,0.00001804654,0.0005171747,0.000003175812,0.00008487675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003731868,"threshold_uncertainty_score":0.01973623,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02199493696951441,"score_gpt":0.3823233804007207,"score_spread":0.3603284434312062,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}